![]() |
市場調查報告書
商品編碼
2062143
美國零售物流:市場佔有率分析、行業趨勢和統計數據、成長預測(2026-2031 年)United States Retail Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
據 Mordor Intelligence 稱,2025 年美國零售物流市場價值為 2352.5 億美元,預計到 2031 年將達到 2959.9 億美元,而 2026 年為 2447.6 億美元,預測期(2026-2031 年)的複合成長率為 3.87%。

零售商正開始將門市轉型為履約中心,溫控網路正在擴展以滿足複雜的生物製藥產品線需求,而聯邦政府的「綠色走廊」計畫正在加速向電動長途運輸車輛的轉型。本報告按服務類型(運輸、倉儲物流及其他)、溫控方式(常溫、冷藏、冷凍、非低溫運輸)、產品類型(食品飲料、服裝鞋帽、消費電子產品、醫療保健及藥品及其他)和地區(東北部、東南部、西南部)進行細分。市場預測以美元計價。
線上購買,商店提 (BOPIS) 模式將數微型倉配,從而實現快速訂單處理。這種模式降低了最後一公里配送成本,同時由於顧客提貨時往往會進行額外購買,因此也增加了門店客流量。隨著大型連鎖店增加對即時庫存可見性和無縫應用程式訂購系統的投入,競爭壓力日益加劇,顧客對速度和可靠性的期望也越來越高。然而,中小零售商往往難以滿足這些期望。隨著郊區人口的成長和電子商務滲透率的提高,BOPIS 正逐漸附加價值服務轉變為標準的履約方式。
生物製藥、細胞和基因療法以及mRNA治療方法的快速發展,推動了對專業低溫儲存和配送基礎設施的需求成長。這些治療方法通常需要嚴格的溫度控制(有時低至-70 度C),因此需要先進的低溫運輸物流、冗餘的電力系統和嚴密監控的運輸網路。波士頓、舊金山和三角研究園區(RTP)等創新叢集正在增加對溫控倉儲和末端配送解決方案的投資,以滿足醫療機構和研究機構的需求。此外,處理敏感生物製藥的複雜性促使物流供應商採用即時追蹤、預測性風險管理和合規運營,從而導致整個藥品供應鏈的複雜性增加和成本結構變化。
內陸帝國、達拉斯/沃斯堡、芝加哥和新澤西州北部等主要物流樞紐的低空置率限制了供應鏈的擴張。由於可用倉庫空間處於歷史低位,租戶面臨租金上漲、位置選擇有限以及獲取倉儲前置作業時間所需時間延長等問題。這種供需失衡在適合電子商務和自動化應用的現代化高層倉庫中尤其嚴重,這類倉庫仍供不應求。因此,租戶被迫選擇位置欠佳或老舊物業,導致運輸效率低下和營運成本增加。短期來看,這些限制因素會降低網路的擴充性,導致擴張計畫延誤,尤其對於快速成長的零售商和第三方物流(3PL) 供應商而言更是如此。
到2025年,運輸服務將占美國零售物流市場佔有率的60.26% 。附加價值服務、套件組裝、逆向物流和貼標服務正以6.66%的複合年成長率成長,反映出零售商正向差異化履約轉型。整合的夥伴關係關係將運輸、倉儲和客製化服務整合在一起,減少了人工操作次數,提高了物流透明度。
倉儲業者正在其物流中心整合簡化的生產工作站、退貨中心和包裹級個人化客製化功能。品牌願意為這些功能支付溢價,因為諸如配送準確率和退貨處理速度等客戶體驗指標直接影響客戶忠誠度。這種轉變正在將倉庫從成本中心轉變為價值鏈中的價值創造樞紐。因此,能夠整合速度、客製化和數據視覺性的營運商正在B2B和D2C(直接面對消費者)市場中獲得競爭優勢。
According to Mordor Intelligence, the united states retail logistics market size was valued at USD 235.25 billion in 2025 and is estimated to grow from USD 244.76 billion in 2026 to reach USD 295.99 billion by 2031, at a CAGR of 3.87% during the forecast period (2026-2031).

Retailers have begun converting stores into fulfillment nodes, temperature-controlled networks are expanding to serve complex biologics pipelines, and federal green-corridor programs are accelerating the shift toward electric line-haul fleets. This report is Segmented by Service Type (Transportation, Warehousing & Distribution, and More), by Temperature-Control (Ambient, Chilled, Frozen, Non Cold Chain), by Product Type (Food and Beverages, Apparel and Footwear, Electronic Appliances, Healthcare & Pharmaceuticals, and More), and by Region (Northeast, Southeast, Southwest). The Market Forecasts are Provided in Terms of Value (USD).
Buy-online-pick-up-in-store (BOPIS) continues to reshape suburban retail logistics by blending digital convenience with physical store networks. Retailers are increasingly redesigning store footprints to accommodate dedicated pickup zones, curbside lanes, and micro-fulfillment backrooms that enable rapid order staging. This model reduces last-mile delivery costs while increasing store traffic, as customers frequently make incremental purchases during pickup visits. The competitive pressure is intensifying as large chains invest in real-time inventory visibility and seamless app-based ordering, raising customer expectations for speed and reliability capabilities that smaller retailers often struggle to match. As suburban populations grow and e-commerce penetration deepens, BOPIS is becoming a default fulfillment option rather than a value-added service.
The rapid growth of biologic drugs, cell and gene therapies, and mRNA-based treatments is driving demand for specialized ultra-cold storage and distribution infrastructure. These therapies often require strict temperature ranges, sometimes as low as -70°C, creating a need for advanced cold chain logistics, redundant power systems, and highly monitored transportation networks. Innovation clusters such as Boston, San Francisco, and Research Triangle Park (RTP) are seeing increased investment in temperature-controlled warehousing and last-mile delivery solutions tailored to healthcare providers and research institutions. The complexity of handling sensitive biologics is also pushing logistics providers to adopt real-time tracking, predictive risk management, and compliance-focused operations, elevating the overall sophistication and cost structure of pharmaceutical supply chains.
Persistently low vacancy rates across major logistics hubs such as the Inland Empire, Dallas-Fort Worth, Chicago, and Northern New Jersey are constraining supply chain expansion. With available warehouse space at historic lows, tenants face rising lease rates, limited location choice, and longer lead times for securing capacity. This imbalance is particularly acute for modern, high-clearance facilities suited for e-commerce and automation, which remain in short supply. As a result, occupiers are forced into suboptimal locations or older assets, increasing transportation inefficiencies and operating costs. In the short term, these constraints limit network scalability and delay expansion plans, especially for fast-growing retailers and third-party logistics providers.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Transportation services generated 60.26% of the 2025 United States retail logistics market share. Value-added offerings, kitting, reverse logistics, and labeling are increasing at 6.66% CAGR, reflecting retailers' shift toward differentiated fulfillment. Integrated partnerships now bundle transportation, warehousing, and customization, reducing hand-offs and improving visibility.
Warehouse operators embed light-manufacturing stations, returns centers, and package-level personalization inside distribution hubs. Brands pay premiums for these capabilities because customer experience metrics such as delivery accuracy and returns turnaround directly drive loyalty. This shift is transforming warehouses from cost centers into value-generating nodes within the supply chain. As a result, operators who can integrate speed, customization, and data visibility are gaining a competitive edge in both B2B and direct-to-consumer markets.